Xiang Li

Title: Innovations in Genetic Engineering by Xiang Li

Introduction

Xiang Li is a prominent inventor based in Dalian, China. He has made significant contributions to the field of genetic engineering, particularly in the production of cordycepin and its derivatives. His innovative work has the potential to enhance production efficiency and promote sustainable practices in biotechnology.

Latest Patents

Xiang Li holds a patent titled "Engineering strain producing cordycepin and its derivative 3'-deoxyinosine, its preparation method and application." This invention relates to genetic engineering and process engineering. The patent discloses a method that includes codon optimizing genes Cm1 and Cm2, gene amplification, and fragment recovering. It also involves methanol-induced promoter and terminator fragments, followed by inserting the genes into an expression vector for screening to obtain the engineering strain. The engineering strain can be applied to the production of cordycepin and its derivative. The method has shown great advantages in producing these compounds, significantly improving production efficiency through the use of unique strains with Cm1 and Cm2 genes.

Career Highlights

Xiang Li is affiliated with Dalian University, where he conducts research and development in genetic engineering. His work has garnered attention for its innovative approach to enhancing the production of valuable biochemicals. His dedication to advancing biotechnology is evident in his research and patent contributions.

Collaborations

Xiang Li collaborates with Huiping Tan, contributing to the advancement of their shared research interests in genetic engineering and biotechnology.

Conclusion

Xiang Li's innovative work in genetic engineering exemplifies the potential for advancements in biotechnology. His patent on the engineering strain for producing cordycepin and its derivatives highlights the importance of sustainable practices in production processes.